Patents for C12R 1 - Micro-organisms (92,025) |
---|
10/22/1996 | US5567614 Enzymatic processes for resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes |
10/22/1996 | US5567603 HIV-3 retrovirus and its use |
10/22/1996 | US5567582 Dna sequences |
10/22/1996 | CA1338664C Recombinant hosts |
10/22/1996 | CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them |
10/17/1996 | WO1996032641A1 Novel protein from dirofilaria immitis and method for immunodiagnosis of heartworm in mammals |
10/17/1996 | WO1996032503A1 Reverse two-hybrid systems |
10/17/1996 | WO1996032498A1 Phycobilisomes, derivatives, and uses therefor |
10/17/1996 | WO1996032495A1 Monoclonal antibody specific for human 4-1bb and cell line producing same |
10/17/1996 | WO1996032488A1 S-adenosyl-l-homocystein hydrolyse promoter |
10/17/1996 | WO1996032482A1 Bacteriocins |
10/17/1996 | WO1996032478A1 Altered polypeptides with increased half-life |
10/17/1996 | WO1996032477A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides |
10/17/1996 | WO1996032417A1 Antibodies against heart muscle actin |
10/17/1996 | WO1996032413A1 Process for the purification of glycoproteins like erythropoietin |
10/17/1996 | WO1996032407A1 Igf-i purification process |
10/17/1996 | WO1996032381A1 Carbazole derivative |
10/17/1996 | WO1996023066A3 Prostaglandin receptor, dp |
10/17/1996 | WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
10/17/1996 | WO1996016173A3 Modified proteinase inhibitors |
10/17/1996 | CA2217901A1 Phycobilisomes, derivatives, and uses therefor |
10/17/1996 | CA2217545A1 Reverse two-hybrid systems |
10/16/1996 | EP0737752A2 Fermentation media and methods for controlling norleucine content in polypeptides |
10/16/1996 | EP0737751A2 Method for producing optically active ester of gamma-substituted-beta-hydroxybutyric acid |
10/16/1996 | EP0737747A2 Cytoplasmatic expression in E. coli of antibodies, antibody fragments and fusions thereof |
10/16/1996 | EP0737690A2 Antihypertensive agent and method for preparing same |
10/16/1996 | EP0737496A1 Image displaying game system and management system for place of amusement |
10/16/1996 | EP0737495A1 Image displaying game machine and image display controlling method |
10/16/1996 | EP0737250A1 Humanized antibodies and uses thereof |
10/16/1996 | EP0737249A1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor |
10/16/1996 | EP0737246A1 BACTERIAL STRAINS OF GENUS $i(BACILLUS) CLOSELY PHENOTYPICALLY RELATED TO GENUS $i(LACTOBACILLUS), CULTURE METHOD AND USE |
10/16/1996 | EP0737208A1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications |
10/16/1996 | EP0737076A1 Method for antigen-specific immunoregulation by t-cell alpha chain |
10/16/1996 | EP0737075A1 Ileal bile acid transporter compositions and methods |
10/16/1996 | EP0598009B1 Continuous natamycin production |
10/16/1996 | EP0432168B1 Genetically engineered coccidiosis vaccine |
10/16/1996 | CN1133598A Acylated insulin |
10/16/1996 | CN1133594A Hsv-2 UL26 gene, capsid proteins, immunoassays and protease inhibitors |
10/16/1996 | CN1133342A Antikanamycin gene originated from microbe |
10/16/1996 | CN1133341A Adjusting and controlling factor for expression of nitrile solution deenzyme and gene thereof |
10/16/1996 | CN1033044C Process for prepn. of optically active acids of 2-aryl alkane |
10/16/1996 | CN1033043C Process for preparation of glucuromide glycoside antibiotic A40926 |
10/16/1996 | CN1033042C Production method for new chlorella |
10/16/1996 | CN1033034C Method for preparation of crystalline interleukin-4 |
10/15/1996 | US5565561 Natural substance cyclamenol and chemical derivatives |
10/15/1996 | US5565559 Culturing an fr-900506; protecting; salt formation; oxidation; reduction; deprotecting |
10/15/1996 | US5565486 Administering culture product of the fungus acremonium strictum as an anticonvulsant, anxiolytic agent, muscle relaxant, hypnotic or memory enhancer |
10/15/1996 | US5565357 Process for production of canthaxanthin |
10/15/1996 | US5565349 Isolated from slime molds; useful in removing dipeptides from n-terminus of genetically engineered peptides |
10/15/1996 | US5565348 Storage stable proteolytic enzyme for detergent mixtures used to remove protein stains from textiles |
10/15/1996 | US5565345 Reduction by the action of a microorganism |
10/15/1996 | US5565343 Fermentation using mutants of kluyveromyces |
10/15/1996 | US5565342 Fermenting sucrose with a synthetase from the microorganism leuconostoc |
10/15/1996 | US5565336 Nucleic acid molecule which codes a human interleukin mutein with increased activity and having a phenylalanine residue at position 171 replaced by leucine and a leucine residue at position 175 replaced by methionine |
10/15/1996 | US5565331 Nucleic acids encoding neural axon outgrowth modulators |
10/15/1996 | US5565330 Method for removing N-terminal dipeptides from precursor polypeptides with dipeptidylaminopeptidase from Dictyostelium discoideum |
10/15/1996 | US5565205 Immunizing a swine against infection |
10/15/1996 | US5565204 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
10/15/1996 | CA1338642C Bacterial methionine n-terminal peptidase |
10/10/1996 | WO1996031617A1 Method of production of antigen-specific glycosylation inhibiting factor |
10/10/1996 | WO1996031611A1 Novel promoters for expressing proteins of interest in yeast |
10/10/1996 | WO1996031610A2 Exopolysaccharide degrading enzyme and use of the same |
10/10/1996 | WO1996031608A1 Plant pathogen resistance genes and uses thereof |
10/10/1996 | WO1996031606A1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
10/10/1996 | WO1996031604A1 Antibodies for the detection of hla-g |
10/10/1996 | WO1996031602A1 Retroviral vectors |
10/10/1996 | WO1996031601A1 Polynucleotide immunogenic agents |
10/10/1996 | WO1996031599A1 Ndf peptides |
10/10/1996 | WO1996031598A1 Tie-2 ligands, methods of making and uses thereof |
10/10/1996 | WO1996031521A1 Inhibiting degradation of a degron-bearing protein |
10/10/1996 | WO1996031242A1 RECOMBINANT β-CELL AND USES THEREOF |
10/10/1996 | DE3991428C2 Bile acid sulphate sulphatase produced by pseudomonas testosterone |
10/10/1996 | DE19512937A1 Neuer Inhibitor des Erythrina caffra Typs und dessen Verwendung zur Reinigung von Serinproteasen New inhibitor of Erythrina caffra type and its use for the purification of serine proteases |
10/10/1996 | CA2218405A1 Novel promoters for expressing proteins of interest in yeast |
10/10/1996 | CA2217652A1 Recombinant .beta.-cell and uses thereof |
10/10/1996 | CA2217491A1 Polynucleotide immunogenic agents |
10/10/1996 | CA2217346A1 Method of production of antigen-specific glycosylation inhibiting factor |
10/10/1996 | CA2216406A1 Plant pathogen resistance genes and uses thereof |
10/10/1996 | CA2215996A1 Exopolysaccharide degrading enzyme and method of use |
10/10/1996 | CA2213620A1 Antibodies for the detection of hla-g |
10/09/1996 | EP0736606A1 Process for the enzymatic preparation of intermediates for the synthesis of befloxatone |
10/09/1996 | EP0736602A2 Siaalpha 2,3Ga1beta 1, 4G1cNAc alpha 2,8-sialyltransferase |
10/09/1996 | EP0736601A2 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
10/09/1996 | EP0736543A2 Method for the production of monoclonal antibodies to proliferation-associated antigens of the cell nucleus |
10/09/1996 | EP0736106A1 Methods of screening for beta-amyloid peptide production inhibitors |
10/09/1996 | EP0736099A1 Expression of self-processing polyproteins in transgenic plants |
10/09/1996 | EP0736098A1 Mycobacteria virulence factors and a method for their identification |
10/09/1996 | EP0736094A1 Polycystic kidney disease 1 gene and uses thereof |
10/09/1996 | EP0736091A1 Muteins of beta-galactosidase fragments having increased activity |
10/09/1996 | EP0736090A1 Oxidation-resistant muteins of beta-galactosidase fragments |
10/09/1996 | EP0736088A1 Monoclonal antibodies to hepatitis e virus and methods for using same |
10/09/1996 | EP0736034A1 Dna encoding the wnt-x growth factor |
10/09/1996 | EP0736002A1 Compound capable of introducing at least one molecule into a cell |
10/09/1996 | EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
10/09/1996 | EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g) |
10/09/1996 | CN1133069A Use of 'alpha'-1,4-glucan lyase for preparation of 1,5-D-anhydrofructose |
10/09/1996 | CN1133068A Subtilisin variants |
10/09/1996 | CN1133066A Genes for butyrobetaine/crotonobetaine-L-carnitine metabolism and their use for microbiological production of L-carine |
10/09/1996 | CN1133063A DNA Molecule encoding for cellular uptake of mycobacterium tuberculosis |
10/09/1996 | CN1133062A H2O2-stable peroxidase variants |